Literature DB >> 7904562

Cyclic guanosine monophosphate mediates penile erection in the rat.

L Martinez-Piñeiro1, F Trigo-Rocha, G L Hsu, B von Heyden, T F Lue, E A Tanagho.   

Abstract

Recent in vivo and in vitro studies suggest that nitric oxide or a nitric-oxide-like substance mediates nonadrenergic, noncholinergic relaxation of trabecular smooth muscle through activation of the cyclic guanosine monophosphate (cGMP) pathway. In 60 Sprague-Dawley rats, we investigated the effect of intracavernous administration of different drugs known to act at different levels of the cyclic adenosine monophosphate (cAMP) and cGMP pathways. Neither cAMP nor drugs that stimulate adenylate cyclase activity (vasoactive intestinal peptide, prostaglandin E1, calcitonin gene-related peptide) provoked any change in the basal intracavernous pressure. N-ethylmaleimide, an inhibitor of the enzyme adenylate cyclase, did not modify the response to electrostimulation of the cavernous nerve, indicating that the cAMP pathway does not play a significant role in penile erection in rats. However, intracavernous administration of methylene blue, a guanylate cyclase inhibitor, significantly reduced the response to electrostimulation (p = 0.001). Direct intracavernous injection of cGMP caused a statistically significant, dose-dependent increase in intravenous pressure that was not significantly inhibited by methylene blue. Sodium nitroprusside, a nitric oxide releaser and therefore a guanylate cyclase activator, caused a dose-dependent increase in intracavernous pressure (p < 0.05) that was inhibited almost completely by methylene blue (p = 0.002), supporting the theory that nitric oxide activates the synthesis of cGMP and that cGMP causes cavernous smooth muscle relaxation. Papaverine elicited an intracavernous pressure increase that was not affected by methylene blue or N-ethylmaleimide, indicating that papaverine acts through an independent pathway.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904562     DOI: 10.1159/000474357

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Effects of intracavernous calcium channel blockers in dogs.

Authors:  S Sarikaya; R Aşçi; Z Aybek; A F Yilmaz; R Büyükalpelli; S Yildiz
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 3.  Neurotransmission and the contraction and relaxation of penile erectile tissues.

Authors:  K E Andersson; C G Stief
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 4.  The future is today: emerging drugs for the treatment of erectile dysfunction.

Authors:  Maarten Albersen; Alan W Shindel; Kuwong B Mwamukonda; Tom F Lue
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

5.  Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase.

Authors:  Doreen E Cashen; D Euan MacIntyre; William J Martin
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

6.  The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction.

Authors:  Xu-Jun Xuan; Gang Bai; Cai-Xia Zhang; Chao Xu; Fu-Ding Lu; Yang Peng; Gang Ma; Cong-Hui Han; Jun Chen
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.